Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)

Publisher Name :
Date: 13-Nov-2017
No. of pages: 215

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Animal Antibiotics and Antimicrobials Market on the basis of Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins and Others), Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others); By Type of Animals (Farm Animals, Companion Animals), By Region (North America, Europe, Europe and Others) and By Country (U.S., Canada, U.K., Germany, France, China, India and Japan).

Over the recent years, the global Animal Antibiotics & Antimicrobials industry has been driven by the rising demand for animal derived food products and increasing healthcare expenditure on pets due to rising pet ownership. Globally, the growth in Animal Antibiotics & Antimicrobials market is driven by growing middle class population.

According to Azoth Analytics research report  “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type,  Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022)” global market is projected to display a robust growth represented by a CAGR of 4.24% by value during 2017 – 2022, chiefly driven by increase in animal population and rising trend of pet ownership among growing middle class income group coupled with rising awareness of animal health.

Among the type, Tetracycline accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large animal population base, growing trend of pet humanization and expanding middle class income group.

The report titled, “Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type,  Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)” has covered and analysed the potential of Global Animal Antibiotics & Antimicrobials Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global animal antibiotics & antimicrobials market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)


  • Global Animal Antibiotics and Antimicrobials Market, By Value

  • By Product Type - Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides,


Sulfonamides, Lincosamides, Cephalosporins and Others)


  • By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others

  • By Delivery Type - Premixes, Oral Powder, Oral Solution, Injections, Others

  • By Type of Animals - Farm Animals, Companion Animals


Regional Markets – North America, Europe, APAC, and ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)


  • Animal Antibiotics and Antimicrobials Market, By Value

  • Animal Antibiotics & Antimicrobials Market, By Product, By Value

  • Animal Antibiotics & Antimicrobials Market, By Delivery Type, By Value

  • Animal Antibiotics & Antimicrobials Market, By Type of Animals, By Value


Country Analysis - US, Canada, UK, Germany, France, China, India, Japan (Actual Period: 2012-2016, Forecast Period: 2017-2022)


  • Animal Antibiotics & Antimicrobials Market, By Value

  • Animal Antibiotics & Antimicrobials Market, By Product Type, By Value

  • Animal Antibiotics & Antimicrobials Market, By Delivery Type, By Value

  • Animal Antibiotics & Antimicrobials Market, By Type of Animals, By Value


Other Report Highlights


  • Market Dynamics – Trends, Drivers, Challenges, Policy and Regulation, Company Analysis – Bayer AG, Merck & Co., Inc., Dechra Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Eli Lilly and Company, Phibro Animal Health Corporation, Ceva Sante Animale, Virbac, Vetoquinol S.A., Zoetis, Inc.


Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Global Animal Antibiotics and Antimicrobials Market Analysis - Product Type, Delivery Type, Type of Animals, Company Analysis, Regional and Country Analysis (2017-2022) – By Product Type (Penicillins, Fluoroguinolones, Aminoglycosides, Tetracyclines, Fluoroguinolones, Macrolides, Sulfonamides, Lincosamides, Cephalosporins, Others), By Delivery Type (Premixes, Oral Powder, Oral Solution, Injections and Others), By Type of Animals (Farm Animals, Companion Animals)

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Global Antibiotics & Antimicrobials Product Outlook

5. Global Antibiotics & Antimicrobials Market: Growth and Forecast
5.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
5.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
5.3. Global Antibiotics & Antimicrobials &   Market - By Product Type, By Value
5.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
5.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
5.4. Global Antibiotics & Antimicrobials &   Market - By Product Type, By Value (2012-2022)
5.4.1. Penicillins, By Value (2012-2022)
5.4.2. Fluoroquinolones, By Value (2012-2022)
5.4.3. Aminoglycosides, By Value (2012-2022)
5.4.4. Tetracyclines, By Value (2012-2022)
5.4.5. Macrolides, By Value (2012-2022)
5.4.6. Sulfonamides, By Value (2012-2022)
5.4.7. Lincosamides, By Value (2012-2022)
5.4.8. Cephalosporins, By Value (2012-2022)
5.4.9. Others, By Value (2012-2022)
5.5. Global Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
5.5.1. Farm Animals, By Value (2012-2022)
5.5.2. Companion Animals, By Value (2012-2022)
5.6. Global Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
5.6.1. Premixes, By Value (2012-2022)
5.6.2. Oral Powder, By Value (2012-2022)
5.6.3. Oral Solution, By Value (2012-2022)
5.6.4. Injections , By Value (2012-2022)
5.6.5. Others, By Value (2012-2022)

6. North America Antibiotics & Antimicrobials Market: Growth and Forecast
6.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.3. North America Antibiotics & Antimicrobials &   Market - By Product Type, By Value
6.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.4. North America Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
6.4.1. Penicillins, By Value (2012-2022)
6.4.2. Fluoroquinolones, By Value (2012-2022)
6.4.3. Aminoglycosides, By Value (2012-2022)
6.4.4. Tetracyclines, By Value (2012-2022)
6.4.5. Macrolides, By Value (2012-2022)
6.4.6. Sulfonamides, By Value (2012-2022)
6.4.7. Lincosamides, By Value (2012-2022)
6.4.8. Cephalosporins, By Value (2012-2022)
6.4.9. Others, By Value (2012-2022)
6.5. North America Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
6.5.1. Farm Animals, By Value (2012-2022)
6.5.2. Companion Animals, By Value (2012-2022)
6.6. North America Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.6.1. Premixes, By Value (2012-2022)
6.6.2. Oral Powder, By Value (2012-2022)
6.6.3. Oral Solution, By Value (2012-2022)
6.6.4. Injections , By Value (2012-2022)
6.6.5. Others, By Value (2012-2022)
6.7. North America Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
6.7.1. North America Medical Gas Market, Country Share, 2012-2016 (% of Total)
6.7.2. North America Medical Gas Market, Country Share, 2017-2022 (% of Total)
6.8. U.S. Antibiotics & Antimicrobials Market: Growth and Forecast
6.8.1. U.S. Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.8.2. U.S. Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.9. U.S. Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.10. U.S. Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
6.10.1. Penicillins, By Value (2012-2022)
6.10.2. Fluoroquinolones, By Value (2012-2022)
6.10.3. Aminoglycosides, By Value (2012-2022)
6.10.4. Tetracyclines, By Value (2012-2022)
6.10.5. Macrolides, By Value (2012-2022)
6.10.6. Sulfonamides, By Value (2012-2022)
6.10.7. Lincosamides, By Value (2012-2022)
6.10.8. Cephalosporins, By Value (2012-2022)
6.10.9. Others, By Value (2012-2022)
6.11. U.S. Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
6.11.1. Farm Animals, By Value (2012-2022)
6.11.2. Companion Animals, By Value (2012-2022)
6.12. U.S. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.12.1. Premixes, By Value (2012-2022)
6.12.2. Oral Powder, By Value (2012-2022)
6.12.3. Oral Solution, By Value (2012-2022)
6.12.4. Injections , By Value (2012-2022)
6.12.5. Others, By Value (2012-2022)
6.13. Canada Antibiotics & Antimicrobials Market: Growth and Forecast
6.13.1. Canada Antibiotics & Antimicrobials Market, By Value (2012-2016)
6.13.2. Canada Antibiotics & Antimicrobials Market, By Value (2017-2022)
6.14. Canada Antibiotics & Antimicrobials & Market - By Product Type, By Value
6.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
6.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
6.15. Canada Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
6.15.1. Penicillins, By Value (2012-2022)
6.15.2. Fluoroquinolones, By Value (2012-2022)
6.15.3. Aminoglycosides, By Value (2012-2022)
6.15.4. Tetracyclines, By Value (2012-2022)
6.15.5. Macrolides, By Value (2012-2022)
6.15.6. Sulfonamides, By Value (2012-2022)
6.15.7. Lincosamides, By Value (2012-2022)
6.15.8. Cephalosporins, By Value (2012-2022)
6.15.9. Others, By Value (2012-2022)
6.16. Canada Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
6.16.1. Farm Animals, By Value (2012-2022)
6.16.2. Companion Animals, By Value (2012-2022)
6.17. Canada Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
6.17.1. Premixes, By Value (2012-2022)
6.17.2. Oral Powder, By Value (2012-2022)
6.17.3. Oral Solution, By Value (2012-2022)
6.17.4. Injections , By Value (2012-2022)
6.17.5. Others, By Value (2012-2022)

7. Europe Antibiotics & Antimicrobials Market: Growth and Forecast
7.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.3. Europe Antibiotics & Antimicrobials &   Market - By Product Type, By Value
7.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.4. Europe Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
7.4.1. Penicillins, By Value (2012-2022)
7.4.2. Fluoroquinolones, By Value (2012-2022)
7.4.3. Aminoglycosides, By Value (2012-2022)
7.4.4. Tetracyclines, By Value (2012-2022)
7.4.5. Macrolides, By Value (2012-2022)
7.4.6. Sulfonamides, By Value (2012-2022)
7.4.7. Lincosamides, By Value (2012-2022)
7.4.8. Cephalosporins, By Value (2012-2022)
7.4.9. Others, By Value (2012-2022)
7.5. Europe Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
7.5.1. Farm Animals, By Value (2012-2022)
7.5.2. Companion Animals, By Value (2012-2022)
7.6. Europe Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.6.1. Premixes, By Value (2012-2022)
7.6.2. Oral Powder, By Value (2012-2022)
7.6.3. Oral Solution, By Value (2012-2022)
7.6.4. Injections , By Value (2012-2022)
7.6.5. Others, By Value (2012-2022)
7.7. Europe Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
7.7.1. Europe Medical Gas Market, Country Share, 2012-2016 (% of Total)
7.7.2. Europe Medical Gas Market, Country Share, 2017-2022 (% of Total)
7.8. U.K. Antibiotics & Antimicrobials Market: Growth and Forecast
7.8.1. U.K. Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.8.2. U.K. Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.9. U.K. Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.10. U.K. Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
7.10.1. Penicillins, By Value (2012-2022)
7.10.2. Fluoroquinolones, By Value (2012-2022)
7.10.3. Aminoglycosides, By Value (2012-2022)
7.10.4. Tetracyclines, By Value (2012-2022)
7.10.5. Macrolides, By Value (2012-2022)
7.10.6. Sulfonamides, By Value (2012-2022)
7.10.7. Lincosamides, By Value (2012-2022)
7.10.8. Cephalosporins, By Value (2012-2022)
7.10.9. Others, By Value (2012-2022)
7.11. U.K. Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
7.11.1. Farm Animals, By Value (2012-2022)
7.11.2. Companion Animals, By Value (2012-2022)
7.12. U.K. Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.12.1. Premixes, By Value (2012-2022)
7.12.2. Oral Powder, By Value (2012-2022)
7.12.3. Oral Solution, By Value (2012-2022)
7.12.4. Injections , By Value (2012-2022)
7.12.5. Others, By Value (2012-2022)
7.13. Germany Antibiotics & Antimicrobials Market: Growth and Forecast
7.13.1. Germany Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.13.2. Germany Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.14. Germany  Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.15. Germany Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
7.15.1. Penicillins, By Value (2012-2022)
7.15.2. Fluoroquinolones, By Value (2012-2022)
7.15.3. Aminoglycosides, By Value (2012-2022)
7.15.4. Tetracyclines, By Value (2012-2022)
7.15.5. Macrolides, By Value (2012-2022)
7.15.6. Sulfonamides, By Value (2012-2022)
7.15.7. Lincosamides, By Value (2012-2022)
7.15.8. Cephalosporins, By Value (2012-2022)
7.15.9. Others, By Value (2012-2022)
7.16. Germany Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
7.16.1. Farm Animals, By Value (2012-2022)
7.16.2. Companion Animals, By Value (2012-2022)
7.17. Germany Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.17.1. Premixes, By Value (2012-2022)
7.17.2. Oral Powder, By Value (2012-2022)
7.17.3. Oral Solution, By Value (2012-2022)
7.17.4. Injections , By Value (2012-2022)
7.17.5. Others, By Value (2012-2022)
7.18. France Antibiotics & Antimicrobials Market: Growth and Forecast
7.18.1. France Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.18.2. France Antibiotics & Antimicrobials Market, By Value (2017-2022)
7.19. France Antibiotics & Antimicrobials & Market - By Product Type, By Value
7.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
7.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
7.20. France Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
7.20.1. Penicillins, By Value (2012-2022)
7.20.2. Fluoroquinolones, By Value (2012-2022)
7.20.3. Aminoglycosides, By Value (2012-2022)
7.20.4. Tetracyclines, By Value (2012-2022)
7.20.5. Macrolides, By Value (2012-2022)
7.20.6. Sulfonamides, By Value (2012-2022)
7.20.7. Lincosamides, By Value (2012-2022)
7.20.8. Cephalosporins, By Value (2012-2022)
7.20.9. Others, By Value (2012-2022)
7.21. France  Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
7.21.1. Farm Animals, By Value (2012-2022)
7.21.2. Companion Animals, By Value (2012-2022)
7.22. France Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
7.22.1. Premixes, By Value (2012-2022)
7.22.2. Oral Powder, By Value (2012-2022)
7.22.3. Oral Solution, By Value (2012-2022)
7.22.4. Injections , By Value (2012-2022)
7.22.5. Others, By Value (2012-2022)
7.23. Rest of Europe Antibiotics & Antimicrobials Market: Growth and Forecast
7.23.1. Rest of Europe  Antibiotics & Antimicrobials Market, By Value (2012-2016)
7.23.2. Rest of Europe  Antibiotics & Antimicrobials Market, By Value (2017-2022)

8. Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
8.1. Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.2. Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.3. Asia-Pacific Antibiotics & Antimicrobials &   Market - By Product Type, By Value
8.3.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.3.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.4. Asia-Pacific Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
8.4.1. Penicillins, By Value (2012-2022)
8.4.2. Fluoroquinolones, By Value (2012-2022)
8.4.3. Aminoglycosides, By Value (2012-2022)
8.4.4. Tetracyclines, By Value (2012-2022)
8.4.5. Macrolides, By Value (2012-2022)
8.4.6. Sulfonamides, By Value (2012-2022)
8.4.7. Lincosamides, By Value (2012-2022)
8.4.8. Cephalosporins, By Value (2012-2022)
8.4.9. Others, By Value (2012-2022)
8.5. Asia-Pacific Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
8.5.1. Farm Animals, By Value (2012-2022)
8.5.2. Companion Animals, By Value (2012-2022)
8.6. Asia-Pacific Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.6.1. Premixes, By Value (2012-2022)
8.6.2. Oral Powder, By Value (2012-2022)
8.6.3. Oral Solution, By Value (2012-2022)
8.6.4. Injections, By Value (2012-2022)
8.6.5. Others, By Value (2012-2022)
8.7. Asia-Pacific Animal Antibiotics & Antimicrobials Market: Country Analysis (U.S., Canada)
8.7.1. Asia-Pacific Medical Gas Market, Country Share, 2012-2016 (% of Total)
8.7.2. Asia-Pacific Medical Gas Market, Country Share, 2017-2022 (% of Total)
8.8. Japan Antibiotics & Antimicrobials Market: Growth and Forecast
8.8.1. Japan Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.8.2. Japan Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.9. Japan Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.9.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.9.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.10. Japan Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
8.10.1. Penicillins, By Value (2012-2022)
8.10.2. Fluoroquinolones, By Value (2012-2022)
8.10.3. Aminoglycosides, By Value (2012-2022)
8.10.4. Tetracyclines, By Value (2012-2022)
8.10.5. Macrolides, By Value (2012-2022)
8.10.6. Sulfonamides, By Value (2012-2022)
8.10.7. Lincosamides, By Value (2012-2022)
8.10.8. Cephalosporins, By Value (2012-2022)
8.10.9. Others, By Value (2012-2022)
8.11. Japan Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
8.11.1. Farm Animals, By Value (2012-2022)
8.11.2. Companion Animals, By Value (2012-2022)
8.12. Japan Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.12.1. Premixes, By Value (2012-2022)
8.12.2. Oral Powder, By Value (2012-2022)
8.12.3. Oral Solution, By Value (2012-2022)
8.12.4. Injections , By Value (2012-2022)
8.12.5. Others, By Value (2012-2022)
8.13. China Antibiotics & Antimicrobials Market: Growth and Forecast
8.13.1. China Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.13.2. China Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.14. China  Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.14.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.14.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.15. China Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
8.15.1. Penicillins, By Value (2012-2022)
8.15.2. Fluoroquinolones, By Value (2012-2022)
8.15.3. Aminoglycosides, By Value (2012-2022)
8.15.4. Tetracyclines, By Value (2012-2022)
8.15.5. Macrolides, By Value (2012-2022)
8.15.6. Sulfonamides, By Value (2012-2022)
8.15.7. Lincosamides, By Value (2012-2022)
8.15.8. Cephalosporins, By Value (2012-2022)
8.15.9. Others, By Value (2012-2022)
8.16. China Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
8.16.1. Farm Animals, By Value (2012-2022)
8.16.2. Companion Animals, By Value (2012-2022)
8.17. China Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.17.1. Premixes, By Value (2012-2022)
8.17.2. Oral Powder, By Value (2012-2022)
8.17.3. Oral Solution, By Value (2012-2022)
8.17.4. Injections , By Value (2012-2022)
8.17.5. Others, By Value (2012-2022)
8.18. India Antibiotics & Antimicrobials Market: Growth and Forecast
8.18.1. India Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.18.2. India Antibiotics & Antimicrobials Market, By Value (2017-2022)
8.19. India Antibiotics & Antimicrobials & Market - By Product Type, By Value
8.19.1. Antibiotics & Antimicrobials, By Value, % (2016)
8.19.2. Antibiotics & Antimicrobials, By Value, % (Forecast 2022F)
8.20. India Antibiotics & Antimicrobials &   Market- By Product Type, By Value (2012-2022)
8.20.1. Penicillins, By Value (2012-2022)
8.20.2. Fluoroquinolones, By Value (2012-2022)
8.20.3. Aminoglycosides, By Value (2012-2022)
8.20.4. Tetracyclines, By Value (2012-2022)
8.20.5. Macrolides, By Value (2012-2022)
8.20.6. Sulfonamides, By Value (2012-2022)
8.20.7. Lincosamides, By Value (2012-2022)
8.20.8. Cephalosporins, By Value (2012-2022)
8.20.9. Others, By Value (2012-2022)
8.21. India Antibiotics & Antimicrobials Market- By  Animal Type, By Value, (2012-2022)
8.21.1. Farm Animals, By Value (2012-2022)
8.21.2. Companion Animals, By Value (2012-2022)
8.22. India Antibiotics & Antimicrobials Market - By Delivery Type, By Value, (2012-2022)
8.22.1. Premixes, By Value (2012-2022)
8.22.2. Oral Powder, By Value (2012-2022)
8.22.3. Oral Solution, By Value (2012-2022)
8.22.4. Injections , By Value (2012-2022)
8.22.5. Others, By Value (2012-2022)
8.23. Rest of Asia-Pacific Antibiotics & Antimicrobials Market: Growth and Forecast
8.23.1. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2012-2016)
8.23.2. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)

9. Rest of Asia-Pacific Antibiotics & Antimicrobials Market, By Value (2017-2022)
9.1. Rising demand for meat heavy diet and Animal derived products
9.2. Increasing ownership and rising spending on pets
9.3. Increasing risk of Animal Borne infectious Diseases

10. Market Restraints

11. Consolidation of the Industry

12. Porter’s Five Forces Analysis – Heart Valve Devices Market

13. SWOT Analysis –Heart Valve Devices Market

14. Policy and Regulations

15. Company Profiles
15.1. Bayer AG
15.2. Merck & Co., Inc.;
15.3. Dechra Pharmaceuticals PLC
15.4. Boehringer Ingelheim GmbH;
15.5. Eli Lilly and Company
15.6. Ceva Sante Animale
15.7. Zoetis, Inc.
15.8. Virbac
15.9. Vetoquinol S.A.
15.10. Phibro Animal Health Corporation

List of Tables

Table A: Food producing Animal & poultry Production, 100 Heads 2010-2014
Table B: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table C: Antimicrobial Drug classes and active ingredients approved for use in food producing-animals, Actively marketed in 2015
Table D: Livestock Statistics Inventories, July 2017
Table E: Holding with cattle and stock of cattle, 2016/17
Table F: Holding with Pigs and stock of Pigs, 2016/17
Table G: Holding with Sheep and stock of Sheep, 2016/17
Table H: Holding with Poultry and stock of Poultry, 2016/17
Table I: Germany Farm Animal Statistics, 2016-2017
Table J: Bovine/Cattle Statistics, (Heads), 2015-2016
Table K: Regulations for the use of antimicrobials in Livestock for growth promotion
Table L: Antibiotics Prohibited for Extra-label use in Food Animals by FDA as of April 1, 2015
Table M: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)
Table N: Prohibited Antibiotics for Use in Seafood as per S.O. 722(E)

List of Figures

Figure 1: Global Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 2: Global Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 3: Live Animal Production, 2010-2014
Figure 4: World Meat Consumption Projections, Million Tones, (2017-2026)
Figure 5: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 6: Global Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 7: Global Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 8: Global Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 9: Global Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 10: North America Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 11: North America Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 12: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 13: North America Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 14: North America Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 15: North America Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 16: North America Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 17: North America Elevators and Escalators Market, Country Share, 2012-2016 (% of Total)
Figure 18: North America Elevators and Escalators Market, Country Share, 2017-2022 (% of Total)
Figure 19: U.S. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 20: Number of households owning pets in millions
Figure 21: Consumption of BEEF Meat in U.S., In Thousand Tones, 2012-2016
Figure 22: Consumption PIG Meat in U.S., In Thousand Tones, 2012-2016
Figure 23: Consumption of Sheep Meat in U.S., In Thousand Tones, 2012-2016
Figure 24: Consumption of Poultry Meat in U.S., In Thousand Tones, 2012-2016
Figure 25: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 26: U.S. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 27: U.S. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 28: U.S. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 29: U.S. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 30: Canada Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 31: Estimated Farm Output of Hogs (X 1000), 2012-2016
Figure 32: Estimated Farm Output of Sheep & Lambs (X 1000), 2012-2016
Figure 33: Canadian Pet Dogs and Cat Population, 2012-2016
Figure 34: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 35: Canada Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 36: Canada Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 37: Canada Animal Antibiotics & Antimicrobials Market- By Animal Type Type, By Value, 2012-2022, (USD Million)
Figure 38: Canada Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 39: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 40: Europe household owing at least one cat or dog-2014
Figure 41: Europe household owing atleast one cat or dog -2015
Figure 42: Pet Ownership Statistics Europe and European Union, 2016
Figure 43: Number of Dairy Cows, EU (28 Countries), 1000 heads 2012-2016
Figure 44: Number of Bovine Animals, 1000 heads, EU (28 countries) 2012-2016
Figure 45: Number of Pigs, EU (28 Countries), 1000 heads, 2012-2016
Figure 46: Europe Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 47: Europe Animal Antibiotics & Antimicrobials Market Share Analysis, By Key Players, 2016
Figure 48: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 49: Europe Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 50: Europe Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 51: Europe Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 52: Europe Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 53: Europe Antibiotics & Antimicrobials Market, Country Share, 2012-2016 (% of Total)
Figure 54: Europe Elevators Antibiotics & Antimicrobials Market, Country Share, 2017-2022 (% of Total)
Figure 55: U.K. Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 56: Cattle on Agriculture Holdings as on 1st December, 2012-2016
Figure 57: Sheep and Lambs on UK agricultural holdings as on 1st June, 2012-2016
Figure 58: Pigs on Agriculture Holdings as on 1st December, 2012-2016
Figure 59: Poultry on UK agricultural holdings as on 1st June, 2012-2016
Figure 60: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 61: U.K. Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 62: U.K. Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 63: U.K. Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 64: U.K. Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 65: Germany Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 66: Pet Ownership in Germany in millions
Figure 67: Share of households owing pet in Germany
Figure 68: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 69: Germany Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 70: Germany Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 71: Germany Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 72: Germany Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 73: France Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 74: Pet Ownership in France in millions
Figure 75: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 76: France Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 77: France Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 78: France Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 79: France Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 80: Rest of Europe Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 81: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2016 (USD Million)
Figure 82: China – Pet ownership
Figure 83: Hong Kong – Pet ownership
Figure 84: Buffaloes Population in Asia, 2012-2014
Figure 85: Cattle Population in Asia, 2012-2014
Figure 86: Goats Population in Asia, 2012-2014
Figure 87: Sheep Population in Asia, 2012-2014
Figure 88: Pigs Population in Asia, 2012-2014
Figure 89: Horses Population in Asia, 2012-2014
Figure 90: Ducks Population (1,000 heads) in Asia, 2012-2014
Figure 91: Chicken Population (1,000 heads) in Asia, 2012-2014
Figure 92: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, Forecast, 2017-2022 (USD Million)
Figure 93: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 94: Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 95: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 96: Asia-Pacific Animal Antibiotics & Antimicrobials Market - By Animal Type, By Value, 2012-2022, (USD Million)
Figure 97: Asia-Pacific Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 98: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2012-2016 (% of Total)
Figure 99: Asia-Pacific Animal Antibiotics & Antimicrobials, Country Share, 2017-2022 (% of Total)
Figure 100: Japan Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 101: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 102: Japan Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 103: Japan – Pet ownership
Figure 104: Japan Spending on Pets in Yen
Figure 105: Japan Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 106: Japan Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 107: Japan Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 108: China Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 109: China Livestock Statistics, 2012-2014
Figure 110: China Livestock Statistics, 2012-2014
Figure 111: Chickens & Ducks (1000 heads), 2012-2014
Figure 112: China pet ownership- 2015
Figure 113: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 114: China Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 115: China Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 116: China Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 117: China Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 118: India Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 119: India Livestock Statistics, 2012-2014
Figure 120: India Livestock Population Statistics, 2012-2014
Figure 121: India Chickens Population Statistics (1000 heads) , 2012-2014
Figure 122: Meat Consumption, (Thousand Tones) 2012-2016
Figure 123: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2016 (%)
Figure 124: India Animal Antibiotics & Antimicrobials Market Size, By Product Type, 2022 (%)
Figure 125: India Animal Antibiotics & Antimicrobials Market- By Product Type, By Value 2012-2022 (USD Million)
Figure 126: India Animal Antibiotics & Antimicrobials Market- By Animal Type, By Value, 2012-2022, (USD Million)
Figure 127: India Animal Antibiotics & Antimicrobials Market- By Delivery Type, By Value, 2012-2022 (USD Million)
Figure 128: Rest of Asia-Pacific Animal Antibiotics & Antimicrobials Market Size, By Value, 2012-2022 (USD Million)
Figure 129: World Meat Consumption, Million Tones, (2012-2016)
Figure 130: Market Share of Global leading players in Animal Antimicrobials & Antibiotics Market, 2016 (%)
Figure 131: Net Sales, By Business Segment, % Share 2016
Figure 132: Net Sales, By Sub Segment, Life Science, % Share 2016
Figure 133: Net Revenue, By Geographic Location, % Share 2016
Figure 134: Net Product Sales& Service Revenue, 2012-2016 (In million USD)
Figure 135: Net Sales, By Geographic Location, % Share 2016
Figure 136: Net Revenue, By Business Segment, % Share 2016
Figure 137: Net Sales, 2012-2016 (In million USD)
Figure 138: Net Revenue, By Product Category, % Share 2016
Figure 139: Net Revenue, By Geographic Location, % Share 2016
Figure 140: Net Sales, 2012-2016 (In million USD)
Figure 141: Net Sales, 2012-2016 (In million USD)
Figure 142: Net Revenue, By Geographic Location, % Share 2016
Figure 143: Net Revenue, By Business Segment Category, % Share 2016
Figure 144: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 145: Net Revenue, By Business Segment Category, % Share 2016
Figure 146: Net Revenue, By Geographic Location, % Share 2016
Figure 147: Net Sales, 2012-2016 (In million USD)
Figure 148: Net Revenue, By Business Segment Category, % Share 2016
Figure 149: Net Sales, 2012-2016 (In million USD)
Figure 150: Net Sales, 2012-2016 (In million USD)
Figure 151: Net Revenue, By Geographic Location, % Share 2016
Figure 152: Net Revenue, By Species, % Share 2016
Figure 153: Net Revenue, By Product Category, Animal Health, % Share 2016
Figure 154: Revenue, By Product Consideration, % Share 2016
Figure 155: Net Sales, 2012-2016 (In million USD)
Figure 156: Net Revenue, By Geographic Location, % Share 2016
Figure 157: Net Revenue, By Type of Animal, % Share 2016
Figure 158: Net Revenue, By Product Category, Companion Animal, % Share 2016
Figure 159: Revenue, By Product Category, Farm Animal, % Share 2016
Figure 160: Net Sales, 2015-2016 (In million USD)
Figure 161: Net Sales, By Geographic Region, % Share 2015-2016 (In million USD)
Figure 162: Net Sales, 2012-2016 (In million USD)
Figure 163: Net Revenue, By Geographic Location, % Share 2016
Figure 164: Net Sales, By Business Segment, % Share 2016
Figure 165: Net Sales, By Product Group, Animal Health, % Share 2016

  • Global Newcastle Disease Vaccine Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 112
    In this report, the global Newcastle Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (M Doses), revenue (Million USD), market share and growth rate of Newcastle Disease Vaccine for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • United States Foot and Mouth Disease (FMD) Vaccines Market Report 2017
    Published: 15-Nov-2017        Price: US 3800 Onwards        Pages: 115
    In this report, the United States Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market sha......
  • Global Animal Antimicrobials Market Professional Survey Report 2017
    Published: 13-Nov-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Animal Antimicrobials in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Zoetis, Inc. - Boehringer Ingelheim GmbH - Eli Lilly and Company......
  • Global Foot and Mouth Disease (FMD) Vaccines Sales Market Report 2017
    Published: 10-Nov-2017        Price: US 4000 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines for these regions, from 2012 to 2022 (forecast), covering - United States ......
  • Global and Regional Veterinary Vaccine Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 130
    Summary Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system's production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. Market Segment as follows: ......
  • Global Newcastle Disease Vaccine Market Research Report 2017
    Published: 03-Nov-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Newcastle Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Newcastle Disease Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • 2017 Animal Health Market Consolidation: Who will not survive?
    Published: 03-Nov-2017        Price: US 2450 Onwards        Pages: 83
    Will the industry consolidate, decentralize, or undergo a bimodal transformation? How will the current trends affect the major market segments? Which companies will enter the market and which will not survive? This new 83-page report from VPGMarketResearch analyzes strategies, marketing tactics and technological know-how of the world’s leading animal health companies, including: Five-year forecasts for: M......
  • United States Animal Wound Care Market Report 2017
    Published: 03-Nov-2017        Price: US 3800 Onwards        Pages: 119
    In this report, the United States Animal Wound Care market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate o......
  • Global Tylosin Market Data Survey Report 2025
    Published: 02-Nov-2017        Price: US 1500 Onwards        Pages: 78
    Summary Tylosin is a macrolide-class broad spectrum antibiotic that's used in veterinary medicine to treat felines, canines and livestock. It is also active against some Gram-negative bacteria, spriochetes, some rickettsia and chlamydia. The drug is only used as an antibiotic in the treatment of infections in livestock. The global Tylosin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including: G......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs